2VD-26119-15874
3 vaccinations
3 coded responses
27 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 024 / MA
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Moderna
- 2021-01-13
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-22
- 2021-01-27
- 2021-02-03
-
2021-02-10
Dose 2 — Moderna
- 2021-02-10
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-02-12
- 2021-02-13
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
-
2021-03-17
Survey response — day 35, dose 2MedDRA: Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: ChilblainsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-24
-
2021-05-12
Survey response — 3 months, dose 2MedDRA: Ovulation delayed — Feeling: GoodFree text: Later than usual ovulation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-11
-
2021-11-09
Dose 3 — Moderna
-
2021-12-22
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-02-10
- 2022-05-10
-
2022-11-09
Survey response — 12 months, dose 3MedDRA: Delivery, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Gave birth and developed postnatal preeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-11-09
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-11-10
-
2022-11-15
Call successfulCompleted over the phone
-
2022-11-30
Callback requested for01:00PM ET
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-10 | Moderna | |
| 3 | 2021-11-09 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-17 | Successful 2021-12-22 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-11-09 | Successful 2022-11-15 |
Completed over the phone |
Free text
Release 5 — day 35, dose 2
Symptoms: Chilblains
Release 8 — 3 months, dose 2
Symptoms: Later than usual ovulation.
Release 12 — 12 months, dose 3
Symptoms: Gave birth and developed postnatal preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Ovulation delayed | ✓ | ✓ | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release